中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
29期
2068-2072
,共5页
李天瑯%徐建飞%王菁%张宏%毛善英%闻树群%周燕
李天瑯%徐建飛%王菁%張宏%毛善英%聞樹群%週燕
리천랑%서건비%왕정%장굉%모선영%문수군%주연
帕金森病%正电子发射断层显像%葡萄糖代谢%多巴胺2型受体%大鼠
帕金森病%正電子髮射斷層顯像%葡萄糖代謝%多巴胺2型受體%大鼠
파금삼병%정전자발사단층현상%포도당대사%다파알2형수체%대서
Parkinson disease%Positron emission tomography%Glucose metabolism%Receptors,dopamine D2%Rats
目的 应用18F-FDG和11C-NMSP microPET评估大鼠帕金森病(PD)模型脑局部葡萄糖代谢及多巴胺2型受体(DRD2)表达的差别及意义.方法 采用6-羟多巴胺制备偏侧PD大鼠模型,2周后应用18F-FDG和11C-NMSPmicroPET扫描,比较PD模型组大鼠和对照组大鼠的脑局部葡萄糖代谢及DRD2表达,用免疫组化染色比较两组的酪氨酸羟化酶表达.结果 PD模型大鼠纹状体、海马、感觉运动皮质葡萄糖代谢率分别为88.2%±2.2%,94.5%±4.5%,96.2%±5.8%,显著低于对照组相应脑区92.7%±2.8%(P<0.01),98.9%±3.9%(P<0.01),102.8%±2.1%(P<0.01);DRD2表达在PD模型的右侧纹状体为112.9%±9.0%,明显高于对照组102.3%±1.4%(P<0.01).结论 PD模型大鼠损毁侧纹状体、海马、感觉运动皮质葡萄糖代谢均降低;而损毁侧纹状体DRD2表达明显升高.18F-FDG和11C-NMSP microPET能有效评估PD模型脑局部葡萄糖代谢及DRD2表达水平,可能成为早期诊断PD的分子影像学工具.
目的 應用18F-FDG和11C-NMSP microPET評估大鼠帕金森病(PD)模型腦跼部葡萄糖代謝及多巴胺2型受體(DRD2)錶達的差彆及意義.方法 採用6-羥多巴胺製備偏側PD大鼠模型,2週後應用18F-FDG和11C-NMSPmicroPET掃描,比較PD模型組大鼠和對照組大鼠的腦跼部葡萄糖代謝及DRD2錶達,用免疫組化染色比較兩組的酪氨痠羥化酶錶達.結果 PD模型大鼠紋狀體、海馬、感覺運動皮質葡萄糖代謝率分彆為88.2%±2.2%,94.5%±4.5%,96.2%±5.8%,顯著低于對照組相應腦區92.7%±2.8%(P<0.01),98.9%±3.9%(P<0.01),102.8%±2.1%(P<0.01);DRD2錶達在PD模型的右側紋狀體為112.9%±9.0%,明顯高于對照組102.3%±1.4%(P<0.01).結論 PD模型大鼠損燬側紋狀體、海馬、感覺運動皮質葡萄糖代謝均降低;而損燬側紋狀體DRD2錶達明顯升高.18F-FDG和11C-NMSP microPET能有效評估PD模型腦跼部葡萄糖代謝及DRD2錶達水平,可能成為早期診斷PD的分子影像學工具.
목적 응용18F-FDG화11C-NMSP microPET평고대서파금삼병(PD)모형뇌국부포도당대사급다파알2형수체(DRD2)표체적차별급의의.방법 채용6-간다파알제비편측PD대서모형,2주후응용18F-FDG화11C-NMSPmicroPET소묘,비교PD모형조대서화대조조대서적뇌국부포도당대사급DRD2표체,용면역조화염색비교량조적락안산간화매표체.결과 PD모형대서문상체、해마、감각운동피질포도당대사솔분별위88.2%±2.2%,94.5%±4.5%,96.2%±5.8%,현저저우대조조상응뇌구92.7%±2.8%(P<0.01),98.9%±3.9%(P<0.01),102.8%±2.1%(P<0.01);DRD2표체재PD모형적우측문상체위112.9%±9.0%,명현고우대조조102.3%±1.4%(P<0.01).결론 PD모형대서손훼측문상체、해마、감각운동피질포도당대사균강저;이손훼측문상체DRD2표체명현승고.18F-FDG화11C-NMSP microPET능유효평고PD모형뇌국부포도당대사급DRD2표체수평,가능성위조기진단PD적분자영상학공구.
Objective To employ 18F-fluoro-2-aeoxyglucose (18 F-FDG) and (3-N-[11 C] methylspiperone ) 11C -NMSP microPET to assess the changes of regional cerebral glucose metabolism and the expression of dopamine receptor type 2 ( DRD2 ) in a rat model of Parkinson's disease (PD). Methods A hemiparkinsonian model was established in rats by unilateral pretreatment with 6-hydroxydopamine (6-OHDA). At 2 weeks after 6-OHDA insult, 18F-FDG and 11C-NMSP microPET scan were performed to compare the differences of regional cerebral glucose metabolism and the expression of DRD2 between the PD and control groups respectively. The immunohistochemical staining was used to detect the expression of tyrosine hydroxylase in two groups. Results In the PD model, the glucose metabolism rates were 88. 2% ± 2. 2%, 94. 5% ±4.5% and 96. 2% ±5. 8% respectively, in right striatum, hippocampus and sensorimotor cortex. And they were significantly lower than those in the control group [ 92. 7% ± 2. 8% ( P < 0. 01 ),98.9% ±3.9% (P<0.01) & 102.8% ±2. 1% (P<0.01) ].The expression of DRD2 in right striatum was significantly higher in the PD group than that in the control group ( 112. 9% ± 9. 0% vs 102. 3% ± 1.4%, P < 0. 01 ). Conclusion In the PD rats, glucose metabolism decreases in injured side striatum,hippocampus and sensorimotor cortex while and the expression of DRD2 increases in injured side striatum.18F-FDG and 11C-NMSP microPET can effectively assess the regional cerebral glucose metabolism and the expression of DRD2 in PD. They may serve as effective molecular imaging tools for an early diagnosis of PD.